Steripath ® Initial Specimen Diversion Device ®, a clinically proven solution, enables hospitals to meet the new goal of 1% blood culture contamination as published in CLSI's M47 Principles and ...

This guidance updates and replaces NICE’s medtech innovation briefing on Kurin Lock for blood culture collection (MIB297). Medical technologies guidance 77 has been migrated to HealthTech guidance 715 ...